Miriam Steinhart (Portrait)

Miriam Steinhart


Immaterialgüter- und Wettbewerbsrecht



Immaterialgüterrecht, Life Science und Biotechnologie, Anreizsysteme im Pharmasektor

Wissenschaftlicher Werdegang

seit 2021
Max-Planck-Institut für Innovation und Wettbewerb

Zweites Juristisches Staatsexamen, München

2018 – 2020
Rechtsreferendariat im Bezirk des OLG München

2017 – 2018
Master of Laws (LL.M.) in Intellectual Property Law, University of Edinburgh, Schottland

Erstes Juristisches Staatsexamen, München

Studium der Rechtswissenschaften
Ludwig-Maximilians-Universität München (LMU)

Beruflicher Werdegang

2018 – 2019
Wissenschaftliche Mitarbeiterin in einer internationalen Wirtschaftskanzlei, München



CRISPR/Cas Technology and Innovation: Mapping Patent Law Issues (Max Planck Institute for Innovation & Competition Research Paper, No. 22-06), 2022, 49 S. (gemeinsam mit Daria Kim et al.).

  • The paper provides a systematic overview of issues arising at the interface between CRISPR/Cas technology and patent law. In particular, it examines aspects related to the patentability of CRISPR/Cas-based methods of genome editing, on the one hand, and access to patented technologies, in view of the expanding CRISPR patent landscape, on the other hand. On the whole, our findings show that the case of CRISPR/Cas technology is prototypical of the policy dilemma in patent law as to how to balance economic incentives of multiple innovators in a cumulative innovation setting. The reviewed technical, legal and economic factors suggest the preconditions for technology underutilisation. While this paper presents the results of the exploratory phase of research, it sets a framework for the further, more targeted interdisciplinary examination of the identified issues.
  • Available at SSRN


Revisiting the Framework for Compulsory Licensing of Patents in the European Union, 2023, 27 S. (gemeinsam mit Matthias Lamping et al.).

  • Within the scope of its initiative on “Compulsory Licensing in the EU”, the European Commission launched a call for evidence on 1 April 2022 and a public consultation on 7 July 2022 with the aim of gathering views from stakeholders. The objective of this initiative is to explore the possibility of revising the framework for compulsory licensing in the EU to make it more “adequately prepared and coordinated to tackle future crises”. The authors of this position paper welcome the Commission’s attempt to reinvigorate the public discourse on this important subject. This paper addresses selected aspects by way of a preliminary, non-exhaustive note on: the proposed reform’s scope and the grounds for a compulsory licence; the requirements of prior negotiation and licensing failure; government use; procedural matters; compulsory licences for patent applications and products; the relation with other regulations and sui generis regimes (i.e. trade secret protection, regulatory data protection, and supplementary protection certificates); the concept of adequate remuneration; compulsory licences for European patents with unitary effect; and the exhaustion of products placed on the market under a compulsory licence.
  • Opinion published as Max Planck Institute for Innovation & Competition Research Paper No. 23-07